Abstract: A fibrous hierarchical zeolite includes a framework comprising aluminum atoms, silicon atoms, and oxygen atoms, the framework further comprising a plurality of micropores and a plurality of mesopores. The framework comprises no Brønsted acid activity.

Abstract: A functionalized fibrous hierarchical zeolite includes a framework comprising aluminum atoms, silicon atoms, and oxygen atoms, the framework further comprising a plurality of micropores and a plurality of mesopores. The functionalized fibrous hierarchical zeolite is functionalized with at least one amine. A plurality of nanoparticles comprising platinum are immobilized on the framework.

Abstract: A functionalized fibrous hierarchical zeolite includes a framework comprising aluminum atoms, silicon atoms, and oxygen atoms, the framework further comprising a plurality of micropores and a plurality of mesopores. The functionalized fibrous hierarchical zeolite is functionalized with at least one terminal amine bonded to a silicon atom. Terminal organometallic functionalities are bonded to a nitrogen atom of the at least one terminal amine, the terminal organometallic functionalities comprising a platinum atom.

Abstract: Oxidized disulfide oil (ODSO) compounds or ODSO compounds and disulfide oil (DSO) compounds are reacted with a hydrogen addition feed in a hydroprocessing complex. The hydrogen addition process can include naphtha hydrotreatment, middle distillate hydrotreatment, vacuum gas oil hydrocracking, and vacuum gas oil hydrotreatment. The ODSO or ODSO and DSO components are converted to hydrogen sulfide, water and alkanes.

Abstract: A functionalized fibrous hierarchical zeolite includes a framework comprising aluminum atoms, silicon atoms, and oxygen atoms, the framework further comprising a plurality of micropores and a plurality of mesopores. The functionalized fibrous hierarchical zeolite is functionalized with at least one amine. A plurality of nanoparticles comprising nickel are immobilized on the framework.

Abstract: Modified crystalline zeolite materials have a zeolite framework with both tetra-coordinate Lewis aluminum single sites and Brønsted aluminum sites. The tetra-coordinate Lewis aluminum single sites include aluminum atoms covalently bonded to a variable group and to two oxygen atoms and further coordinated to a third oxygen atom. The variable group may be alkyl, hydride, or hydroxyl. Methods for incorporating tetra-coordinate Lewis aluminum single sites into a crystalline zeolite material include contacting the crystalline zeolite material with a dialkylaluminum hydride R2AlH, where each R is alkyl, to react the dialkylaluminum hydride with the zeolite framework and form tetra-coordinate alkyl aluminum single sites. Heating the alkyl-aluminum zeolite induces ?-hydride elimination of the alkyl groups, whereby tetra-coordinate aluminum hydride single sites are formed.

Abstract: A functionalized fibrous hierarchical zeolite includes a framework comprising aluminum atoms, silicon atoms, and oxygen atoms, the framework further comprising a plurality of micropores and a plurality of mesopores. A plurality of nanoparticles comprising platinum are immobilized on the framework.

Abstract: A process for upgrading a hydrocarbon feed includes passing the hydrocarbon feed and an aromatic bottoms stream to an FCC unit including an FCC reactor and a catalyst regenerator. The hydrocarbon feed is hydrogen-rich having at least 12 wt. % hydrogen, and the aromatic bottoms stream is a bottoms stream produced from an aromatics recovery complex for processing reformate from naphtha reforming. The hydrocarbon feed and aromatic bottoms stream are cracked over the FCC catalysts to produce an effluent and spent FCC catalysts having coke deposits. The spent FCC catalyst is regenerated through combustion of the coke deposits. The hydrogen-rich hydrocarbon feed does not produce enough coke to satisfy the heat demand of the FCC reactor. Cracking the aromatic bottoms stream increases the amount of coke so that combustion of the additional coke during regeneration produces additional heat to satisfy the heat demand of the FCC reactor.

Abstract: Disclosed herein are modified zeolites and methods for making modified zeolites. In one or more embodiments disclosed herein, a modified zeolite may include a microporous framework including a plurality of micropores having diameters of less than or equal to 2 nm. The microporous framework includes at least silicon atoms and oxygen atoms. The modified zeolite may further include organometallic moieties each bonded to bridging oxygen atoms. The organometallic moieties include a hafnium atom. The hafnium atom is bonded to a bridging oxygen atom, and bridging oxygen atom bridges the hafnium atom of the organometallic moiety and a silicon atom of the microporous framework.

Abstract: Disclosed herein are modified zeolites and methods for making modified zeolites. In one or more embodiments disclosed herein, a modified zeolite may include a microporous framework comprising a plurality of micropores having diameters of less than or equal to 2 nm. The microporous framework may include at least silicon atoms and oxygen atoms. The modified zeolite may further include organometallic moieties each bonded to bridging oxygen atoms. The organometallic moieties may include a titanium atom. The titanium atom may be bonded to a bridging oxygen atom, and the bridging oxygen atom may bridge the titanium atom of the organometallic moiety and a silicon atom of the microporous framework.

Abstract: A method is provided for lowering blood sugar in a subject in need thereof by administering a gliflozin Sodium-Glucose Cotransport 2 inhibitor pharmaceutical composition to a subject qualified for over-the-counter access to the gliflozin Sodium-Glucose Cotransport 2 inhibitor pharmaceutical composition. In some embodiments, the gliflozin Sodium-Glucose Cotransport 2 inhibitor pharmaceutical composition includes empagliflozin, canagliflozin, and ertugliflozin. In some embodiments, the gliflozin Sodium-Glucose Cotransport 2 inhibitor pharmaceutical composition includes (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol or a pharmaceutically acceptable salt thereof.

Abstract: Methods, apparatus, systems and articles of manufacture to monitor media presentations are disclosed. An example tangible computer readable storage medium includes instructions that, when executed, cause a machine to at least instrument media with monitoring instructions; provide the instrumented media to a media device via a hypertext transport secure protocol, the monitoring instructions to cause the media device to request a panelist identifier associated with the media device; detect a media event based on an action of the media device; determine media-identifying information based on the media event; and generate a record including the media-identifying information and the panelist identifier.

Abstract: A method is provided for lowering blood sugar in a subject in need thereof by administering a biguanide anti-hyperglycemic pharmaceutical composition to a subject qualified for over-the-counter access to the biguanide anti-hyperglycemic pharmaceutical composition. In some embodiments, the biguanide anti-hyperglycemic pharmaceutical composition includes N,N-dimethylimidodicarbonimidic diamide, or a pharmaceutically acceptable salt thereof. In some embodiments, the biguanide anti-hyperglycemic pharmaceutical composition includes metformin hydrochloride.

Abstract: A drill bit for drilling a borehole in an earthen formation has a central axis and a cutting direction of rotation. The bit includes a bit body configured to rotate about the axis in the cutting direction of rotation. The bit body includes a bit face. The bit also includes a blade extending radially along the bit face. In addition, the bit includes a first cutter element mounted to a cutter-supporting surface of the blade and a second cutter element mounted to the cutter-supporting surface of the blade. The first cutter element has a central axis and includes a first forward-facing cutting face including a first cutting tip distal the cutter supporting surface and a first planar surface extending radially from the first cutting tip toward the central axis of the first cutter element. The first planar surface is oriented at a first effective backrake angle measured between the cutter supporting surface and a surface vector of the first planar surface.

Abstract: The present invention relates to novel compounds, pharmaceutical compositions containing such compounds and to their use in therapy.

Abstract: A wiper blade connector releasably secures a wiper blade to a wiper arm, thereby forming a windshield wiper blade assembly. The wiper blade connector comprises an elongate body member having opposite facing side walls, a front end, and a rear end. The opposite facing sidewalls include means for receiving and releasably securing to the mounting base on a wiper blade. At the front end of the elongate body member, a first tongue receiving opening is sized to receive the corresponding front tongue of a wiper arm. At the rear end of the elongate body member, a second tongue receiving opening is sized to receive the corresponding rear tongue of a wiper arm. A locking mechanism, such as a slidable cap provided proximate to the front end of the elongate body member, releasably locks the wiper blade member to the wiper arm.

Abstract: Disclosed herein are modified zeolites and methods for making modified zeolites. In one or more embodiments disclosed herein, a modified zeolite may include a microporous framework including a plurality of micropores having diameters of less than or equal to 2 nm. The microporous framework may include at least silicon atoms and oxygen atoms. The modified zeolite may further include organometallic moieties each bonded to bridging oxygen atoms. The organometallic moieties may include a platinum atom. The platinum atom may be bonded to a bridging oxygen atom, and the bridging oxygen atom may bridge the platinum atom of the organometallic moiety and a silicon atom of the microporous framework.

Abstract: The present invention relates to compositions comprising factor VIII coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of factor VIII-related diseases, disorders, and conditions.

Abstract: A system for sending one or more electronic messages to one or more intended recipients each having access to an electronic communication device is provided. The electronic messages include a predefined address format and the one or more intended recipients are associated with one or more fixed geographic locations. The system includes a sender user interface operable to enable a sender to create and send one or more electronic messages to one or more predefined message addresses. The system further includes a computer processor in communication with the sender user interface and configured to resolve the one or more predefined addresses with respective associated fixed geographic locations, and forward the one or more electronic messages to one or more electronic message accounts associated with the one or more predefined addresses.

Abstract: Oxidized disulfide oil (ODSO) compounds or ODSO compounds and disulfide oil (DSO) compounds are reacted with a hydrogen addition feed in a hydroprocessing complex. The hydrogen addition process can include naphtha hydrotreatment, middle distillate hydrotreatment, vacuum gas oil hydrocracking, and vacuum gas oil hydrotreatment. The ODSO or ODSO and DSO components are converted to hydrogen sulfide, water and alkanes.